7 th CENTRAL EUROPEAN CONGRESS ON OSTEOPOROSIS AND OSTEOARTHRITIS

Transcription

1 7 th CENTRAL EUROPEAN CONGRESS ON OSTEOPOROSIS AND OSTEOARTHRITIS 19 TH CONGRESS OF THE POLISH OSTEOARTHROLOGY SOCIETY AND THE POLISH FOUNDATION OF OSTEOPOROSIS Krakow, Preliminary Programme

2 CONGRESS VENUE Auditorium Maximum Jagiellonian University Medium Hall ul. Krupnicza 33, Kraków OPENING OF THE CONGRESS (Friday) at 9.00 CLOSING CEREMONY (Saturday) at Deadline for abstract submission CONTACT Organizing Committee 7 th Central European Congress on Osteoporosis and Osteoarthritis ul. Kopernika Kraków Tel.: (48) krakow@osteoporoza.pl ONLINE REGISTRATION FEES: Congress fee for participants * - until (early*) 490zł (inc. VAT) - from (regular) 590zł (inc. VAT) - from (on-site) - 800zł (inc VAT) * The date of receipt of funds on the account is decisive. CONGRESS FEE INCLUDES - programme booklet, - USB flash drive with abstracts, - ID card, - lunch on and , - coffee breaks, - entry to the lecture hall and commercial, exhibition, - wi-fi at Auditorium Maximum (Congress Venue) ORGANISING COMMITTEE Chairman: Vice-Chairman: Edward Czerwiński Jarosław Amarowicz Members: Małgorzata Berwecka Przemysław Borowy Monika Cholewińska Agata Jaśkowiec Anna Kumorek Jolanta Osieleniec Maja Warzecha Dominika Wójcik Kinga Zajączkowska

3 SCIENTIFIC COMMITTEE Prof. dr hab. med. Janusz E. Badurski Prof. dr hab. med. Dariusz Białoszewski Prof. dr hab. med. Danuta Chlebna-Sokół Prof. dr hab. med. Cyrus Cooper Prof. dr hab. med. Edward Czerwiński Prof. dr hab. med. Edward Franek Prof. dr hab. med. Piotr Głuszko Prof. dr hab. med. Tomasz Grodzicki Prof. dr hab. med. Mirosław Jabłoński Prof. dr hab. med. Jolanta Jaworek Prof. John A. Kanis Dr hab. med. Jerzy Konstantynowicz Prof. dr hab. med. Mariusz Korkosz Prof. dr hab.med. Eugeniusz Kucharz Prof. Olga Lesniak Dr hab. med. Piotr Leszczyński Prof. dr hab. med. Roman S. Lorenc Prof. dr hab. med. Ewa Marcinowska -Suchowierska Dr n. med. Waldemar Misiorowski Prof. Vladimir Palicka Prof. Socrates E. Papapoulos Prof. Vladislaw Povorozniuk Prof. dr hab. med. Wojciech Pluskiewicz Prof. dr hab. med. Jerzy Przedlacki Prof. Jean-Yves Reginster Dr med. Andrzej Sawicki Prof. dr hab. med. Ewa Sewerynek Prof. dr hab. med. Andrzej Więcek Dr hab. med. Grażyna Wyszyńska-Pawelec Prof. dr hab. med. Andrzej Żyluk Białystok, Poland Łódź, Poland Southampton, Great Britain Lublin, Polska Sheffield, Great Britain Białystok, Poland Katowice, Poland Moskwa, Russia Poznań, Poland Hradec Kralove, Czech Republic Leiden, Netherlands Kijów, Ukraine Zabrze, Poland Liege, Belgium Łódź, Poland Katowice, Poland Szczecin, Poland

4 CONGRESS TOPICS I. Main Topics - Osteoporosis Advances in diagnostics and treatment of osteoporosis Long-term treatment of osteoporosis New drugs in osteoporosis Preventing complications in osteoporosis treatment Osteoporosis in men Osteoporosis in systemic connective tissue diseases Osteoporosis in young adults Secondary osteoporosis Vertebral fractures II. Healthy aging and sarcopenia Definition of sarcopenia Falls - causes and prevention III. Osteoarthritis Advances in pharmacological treatment Physiotherapy Analgesic treatment IV. Free topics CONGRESS ABSTRACTS SUBMISSION The Committee invites participants to submit scientific papers that will be anonymously evaluated by two independent reviewers. The best articles will be qualified for presentation in the form of a poster or lecture. Online abstract submission is available (with all information on the process) at The deadline for abstract submission is HOTEL JORDAN Congress Bureau is in charge of the hotel accommodation for the Congress participants. Complete list of the accommodation options is available on

5 PRELIMINARY PROGRAMME DAY I (Friday) time' 9.00 Congress inauguration 20' S Advances in diagnostics and treatment of osteoporosis 80' The burden of osteoporotic fractures in Poland Borowy P. Use of VFA in the diagnosis of asymptomatic vertebral fractures Leszczyński P. Application of TBS in fracture risk assessment in osteopenia Amarowicz J. FRAX efficacy in the prevention of osteoporotic fractures (SCOOP) Kanis J. Therapeutic decisions in osteoporosis Czerwiński E. Coffee break S Long-term treatment of osteoporosis 70' Denosumab in long-term treatment of osteoporosis Czerwiński E. Denosumab and bisphosphonates Korkosz M. To stop or not stop the therapy? How long we should treat osteoporosis? Clinical aspects of drug interactions in osteoporosis Sewerynek E. Marcinowska- Suchowierska E. S New strategies in osteoporosis treatment 80' Efficacy of romososumab in fracture prevention Papapoulos S. Abaloparatide in osteoporosis treatment Franek E. Closing the Treatment Gap in Osteoporosis Cooper C Lunch / Poster session 60' S Complications in osteoporosis treatment 80' Bisphosphonates - indications (SPC) and contraindications Pluskiewicz W. Atypical fractures - diagnosis and treatment Czerwiński E. Osteonecrosis of the jaw - methods of prevention Wyszyńska- Pawelec G. Treatment of vertebral fractures Jabłoński M. Complex regional pain syndrome (Sudeck's atrophy) Żyluk A.

6 S Round-table discussion: Difficult decisions 70' Czerwiński E., Sewerynek E., Sawicki A., Batko B., Rell- Bakalarska M. S Supplementation in osteoporosis 80' Standards of supplementation and treatment of vitamin D deficiency in adults Marcinowska- Suchowierska E. Vitamin K - truth and myths Misiorowski W. Is vitamin D efficient in falls prevention? Berwecka M. Sarcoidosis - disorder of bone metabolism Kucharz E. Calcium supplementation and the cardiovascular risks Przedlacki J. DAY II (Saturday) S Osteoporosis - not only postmenopausal 110' Diagnostic algorithm of osteoporosis in endocrinopathies Franek E. Steroid-induced osteoporosis - guidelines Głuszko P. Osteoporosis in men - diagnostic algorithm Misiorowski W. Management of mineral bone disorders in chronic kidney diseases (CKD-MBD) Osteoporosis in the course of pharmacotherapy of breast and prostate cancer Więcek A. Kalinka - Warzocha E. Osteoporosis in systemic connective tissue diseases Osieleniec J. Coffee break S Advances in the treatment of osteoarthritis 105' Advances in osteoarthritis treatment Reginster J-Y. Intra-articular drugs for the treatment of osteoarthritis Białoszewski D. Painful conflicts in the musculoskeletal system Badurski J. Pain management in osteoarthritis Woroń J. Physiotherapy (EBM) in the treatment of osteoarthritis Jaworek J. S Aging and sarcopenia 90' Healthy aging Grodzicki T. The most recent definition of sarcopenia Berwecka M. Sarcopenia - prevention and treatment Povoroznyuk V. Falls risk assessment, strength, gait speed, muscle mass Warzecha M Lunch / Poster session 60'

7 S The increase of the untreated possible interventions 70' Why fewer and fewer people are being treated for osteoporosis? Lesnyak O. FLS - our experiences from System Zapobiegania Złamaniom Amarowicz J. Coordination programme of osteoporotic fractures prevention Głuszko P. S Other 90' Role of genetics in fracture risk prediction Palicka V. Congenital bone fragility (Osteogenesis imperfecta) in adults Konstantynowicz J. Current place of bone markers in the management of osteoporosis Lorenc R. Bone metabolism disorders in rare diseases Borowy P. FRAX and TBS in fracture risk assessment Berwecka M. Use of new ultrasound techniques in the diagnosis of osteoporosis TBA Closing ceremony Program wstepny_6_eng_ N:\05_VII_Euro_Kongres_OP_i_OA_ \09_Program\Program wstepny_6_eng_ docx